Skip to main content
. 2021 Jan-Feb;66(1):67–73. doi: 10.4103/ijd.IJD_206_20

Table 4.

Changes in IFN-γ between treatment arms

IFN PPD group (n=9) Mw group (n=11) MMR group (n=12) P (between groups)
Baseline 21.06±36.32 30.92±41.11 24.29±22.27 0.690
0.9 (0.6, 25.25) 21 (0.6, 28.75) 18 (12, 33.5)
End of treatment 19.78±29.53 50.62±61.92 54.15±84.80 0.466
3 (0.48, 37.75) 33 (21.25, 59.5) 84.80 (0.5, 52)
P (within groups) 0.820 0.413 0.052

P-value for between groups by Kruskal–Wallis ANOVA. P-value for within groups by Wilcoxon test